期刊文献+

盐酸阿呋唑嗪合成工艺改进 被引量:2

Improved synthesis of alfuzosin hydrochloride
原文传递
导出
摘要 目的合成盐酸阿呋唑嗪并优化其工艺。方法以藜芦酸为原料,其甲酯经混酸硝化后,在Lewis酸氯化铵溶液存在下经Fe粉还原,再依次经尿素环合、三氯氧磷氯代和氨水氨解,得到关键中间体2-氯-4-氨基-6,7-二甲氧基喹唑啉(6)。化合物6与3-甲氨基丙腈缩合,经Raney Ni-H2催化还原得N-甲基-N-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-1,3-丙二胺(8),8与2-四氢呋喃甲酸缩合后再与盐酸成盐,制得目标物盐酸阿呋唑嗪。结果与结论目标化合物的结构经MS、1H-NMR谱确证。该工艺路线操作简单,总收率由文献的7.8%提高到25.9%。 Aim To improve the synthesis of alfuzosin hydrochloride and to optimize its process.Methods The key intermediate,2-chloro-4-amino-6,7-dimethoxyquinazoline(6),was obtained from methyl ester of veratryl acid via nitration,reduction by powdered-Fe in the presence of aqueous NH4Cl,cyclization with urea,chlorination with phosphorus oxychloride and eventually aminolysis with aqueous ammonia.Compound 6 reacted with 3-methyl aminopropionitrile followed by the catalytic reduction of the nitrile with Raney Ni-H2 to afford the desired amine N2-(3-aminopropyl)-6,7-dimethoxy-N2-methylquinazoline-2,4-diamine(8).8 was condensed with 2-tetrahydrofuroic acid and then treated with hydrogen chloride in methanol to give the target in hydrochloride form.Results and conclusion The structure of target compound was confirmed by MS and 1H-NMR.The total yield was increased from 7.8% reported by literature to 25.9% by simplifying the process of the route.
出处 《中国药物化学杂志》 CAS CSCD 2009年第5期352-355,共4页 Chinese Journal of Medicinal Chemistry
关键词 盐酸阿呋唑嗪 良性前列腺增生 工艺改进 alfuzosin hydrochloride benign prostatic hyperplasia process improvement
  • 相关文献

参考文献3

二级参考文献17

  • 1邓方明,夏同礼,顾方六,郭应禄.正常前列腺和前列腺增生的组织形态学定量研究[J].中华泌尿外科杂志,1995,16(12):708-710. 被引量:27
  • 2陈玉彬,赵翔.特拉唑嗪合成路线图解[J].中国医药工业杂志,1996,27(12):559-561. 被引量:3
  • 3[1]Manoury PM. 4-Amino-6,7-dimethoxyquinazol-2-yl-alkyl enediamine [P]. US:4315007, 1982-02-09. (CA 1982, 96:162737e)
  • 4[2]Manoury PM. Synthesis and antihypertensive activity of a series of 4-amino-6,7-dimethoxyquinazoline derivatives [J]. J Med Chem, 1986, 29:19-25.
  • 5[3]Jozsef R, Laszlo P, Frigyes G, et al. Preparation of quinazolin e derivatives as antihypertensives [P]. GB:2231571, 1990-11-21. (CA 1991, 115:29365b)
  • 6[4]Sinna SKP, Chaudhury DN. 4-Quinazolones: part VI. Synthesis of an angular furoquinazolone [J]. J Indian Chem Soc, 1970, 47:925-930.
  • 7[5]Muellner FW, Baner L, et al. The synthesis of 1,4-ethanol-1, 2,3,4-tetrahydroisoquinolines as rigid analogues of adrenergic agents [J]. J Heterocyclic Chem, 1983, 20:1581-1584.
  • 8[6]Dunkel M, Pfleiderer W. Synthesis and properties of quinazoline- N-ribofuranosides [J]. Nucleosides & Nucleotides, 1991, 10:799 -817.
  • 9[7]Hess HH, Crowin TH, Soriabine A. Antihypertensive 2-amino-4-(3 H)-quinazolinones [J]. J Med Chem, 1968, 11:130-136.
  • 10[8]Althuis TH, Hess HJ. Synthesis and identification of the major me tabolites of prazosin formed in dog and rat [J]. J Med Chem, 1977, 20:146-149.

共引文献7

同被引文献23

  • 1姚子鹏,蔡智呜.含氮六元芳杂环的亲核取代反应[J].大学化学,1995,10(3):28-32. 被引量:4
  • 2Joshi N S. Processes for the preparation of alfuzosin and salts thereof and novel crystaline forms of alfuzosin : WO : 090268 [P]. 2006-08-31.
  • 3Sadanand N S. Processes for the preparation of alfuzosin: WO, 144699[P]. 2007-12-21.
  • 4Manoury P M, Binet J L, Dumas A P, et al. Synthesis and antihypertensive activity of a series of 4-amino-6,7- dimethoxyquuinazoline derivatives [J]. J Med Chem, 1986, 29 (1): 19-25.
  • 5赵志全.盐酸阿夫唑嗪的制备方法:中国,1616438A[P].2005-05-18.
  • 6Raghupathi R A. Preparation of alfuzosin : US, 0066824 A1 [P]. 2007-05-22.
  • 7Manne S R, Bairy K R, Chepyala K R, et al. An improved and commercially viable process for the prepara- tion of alfuzosin hydrochloride[J].Arkivo, 2007, 8: 41-46.
  • 8胡高云.阿夫唑嗪的制备方法:中国,1935806A[P].2007-03-28.
  • 9Ahhuis T H, Hess H J. Synthesis and identification of the major metabolites of prazosin formed in dog and rat [J]. J Med Chem, 1977, 20: 146-149.
  • 10Regnier F. Alfuzosine compositions and use [ P]. US :4661491, 1987-04-28.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部